ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/21 | 1,316 | 1,317 | 1,270 | 1,285 | -44 | -3.3% | 771,100 |
| 2022/09/20 | 1,372 | 1,376 | 1,321 | 1,329 | -42 | -3.1% | 553,200 |
| 2022/09/16 | 1,386 | 1,386 | 1,353 | 1,371 | -30 | -2.1% | 637,700 |
| 2022/09/15 | 1,425 | 1,432 | 1,392 | 1,401 | -14 | -1% | 397,700 |
| 2022/09/14 | 1,404 | 1,434 | 1,393 | 1,415 | -44 | -3% | 661,500 |
| 2022/09/13 | 1,456 | 1,485 | 1,456 | 1,459 | -13 | -0.9% | 323,400 |
| 2022/09/12 | 1,513 | 1,520 | 1,467 | 1,472 | -32 | -2.1% | 491,800 |
| 2022/09/09 | 1,484 | 1,517 | 1,476 | 1,504 | +40 | +2.7% | 696,100 |
| 2022/09/08 | 1,477 | 1,484 | 1,456 | 1,464 | +17 | +1.2% | 637,200 |
| 2022/09/07 | 1,538 | 1,543 | 1,406 | 1,447 | -106 | -6.8% | 1,687,600 |
| 2022/09/06 | 1,547 | 1,573 | 1,535 | 1,553 | -1 | -0.1% | 430,300 |
| 2022/09/05 | 1,552 | 1,569 | 1,538 | 1,554 | -20 | -1.3% | 387,200 |
| 2022/09/02 | 1,566 | 1,576 | 1,538 | 1,574 | +28 | +1.8% | 437,300 |
| 2022/09/01 | 1,547 | 1,562 | 1,535 | 1,546 | -19 | -1.2% | 337,800 |
| 2022/08/31 | 1,561 | 1,579 | 1,545 | 1,565 | -12 | -0.8% | 458,800 |
| 2022/08/30 | 1,552 | 1,587 | 1,547 | 1,577 | +33 | +2.1% | 581,500 |
| 2022/08/29 | 1,572 | 1,594 | 1,538 | 1,544 | -90 | -5.5% | 1,082,000 |
| 2022/08/26 | 1,636 | 1,697 | 1,612 | 1,634 | ±0 | ±0% | 1,108,600 |
| 2022/08/25 | 1,649 | 1,671 | 1,632 | 1,634 | -15 | -0.9% | 615,500 |
| 2022/08/24 | 1,640 | 1,675 | 1,626 | 1,649 | +6 | +0.4% | 608,100 |
| 2022/08/23 | 1,645 | 1,682 | 1,634 | 1,643 | -16 | -1% | 780,900 |
| 2022/08/22 | 1,663 | 1,682 | 1,623 | 1,659 | -41 | -2.4% | 1,115,000 |
| 2022/08/19 | 1,730 | 1,749 | 1,652 | 1,700 | -29 | -1.7% | 2,135,200 |
| 2022/08/18 | 1,815 | 1,815 | 1,707 | 1,729 | -135 | -7.2% | 2,115,800 |
| 2022/08/17 | 1,950 | 1,965 | 1,854 | 1,864 | -113 | -5.7% | 2,108,000 |
| 2022/08/16 | 1,843 | 2,015 | 1,831 | 1,977 | +187 | +10.4% | 3,356,200 |
| 2022/08/15 | 1,792 | 1,830 | 1,762 | 1,790 | -16 | -0.9% | 1,019,000 |
| 2022/08/12 | 1,774 | 1,822 | 1,755 | 1,806 | +22 | +1.2% | 1,095,100 |
| 2022/08/10 | 1,988 | 1,990 | 1,767 | 1,784 | -185 | -9.4% | 2,421,500 |
| 2022/08/09 | 1,863 | 1,975 | 1,858 | 1,969 | +111 | +6% | 1,502,000 |
| 2022/08/08 | 1,811 | 1,866 | 1,785 | 1,858 | +23 | +1.3% | 902,700 |
| 2022/08/05 | 1,890 | 1,908 | 1,825 | 1,835 | -48 | -2.5% | 1,139,500 |
| 2022/08/04 | 1,860 | 1,904 | 1,851 | 1,883 | +58 | +3.2% | 1,334,400 |
| 2022/08/03 | 1,820 | 1,867 | 1,807 | 1,825 | +43 | +2.4% | 1,192,100 |
| 2022/08/02 | 1,735 | 1,826 | 1,734 | 1,782 | -6 | -0.3% | 1,191,800 |
| 2022/08/01 | 1,850 | 1,859 | 1,748 | 1,788 | -75 | -4% | 1,500,200 |
| 2022/07/29 | 1,792 | 1,893 | 1,779 | 1,863 | +88 | +5% | 2,070,400 |
| 2022/07/28 | 1,745 | 1,786 | 1,708 | 1,775 | +29 | +1.7% | 1,510,100 |
| 2022/07/27 | 1,625 | 1,757 | 1,625 | 1,746 | +134 | +8.3% | 1,857,800 |
| 2022/07/26 | 1,544 | 1,615 | 1,537 | 1,612 | +62 | +4% | 517,600 |
| 2022/07/25 | 1,558 | 1,587 | 1,524 | 1,550 | -30 | -1.9% | 603,900 |
| 2022/07/22 | 1,558 | 1,594 | 1,533 | 1,580 | +1 | +0.1% | 624,500 |
| 2022/07/21 | 1,526 | 1,624 | 1,524 | 1,579 | +51 | +3.3% | 1,376,700 |
| 2022/07/20 | 1,497 | 1,547 | 1,468 | 1,528 | +2 | +0.1% | 885,200 |
| 2022/07/19 | 1,498 | 1,555 | 1,422 | 1,526 | +110 | +7.8% | 2,297,500 |
| 2022/07/15 | 1,387 | 1,452 | 1,367 | 1,416 | +41 | +3% | 1,125,800 |
| 2022/07/14 | 1,272 | 1,375 | 1,258 | 1,375 | +101 | +7.9% | 688,600 |
| 2022/07/13 | 1,266 | 1,281 | 1,253 | 1,274 | -5 | -0.4% | 225,500 |
| 2022/07/12 | 1,255 | 1,293 | 1,253 | 1,279 | +2 | +0.2% | 333,500 |
| 2022/07/11 | 1,303 | 1,310 | 1,276 | 1,277 | -7 | -0.5% | 235,500 |
501～
550
件表示中 / 3553件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.21倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 科研薬 | 386,000円 | +22.8% | +113.0% | 4.92% | 10.29倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 316,000円 | +14.7% | -21.6% | 1.90% | 12.35倍 | 1.00倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 持田薬 | 348,000円 | +3.0% | +27.5% | 2.30% | 22.03倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 232,400円 | +9.6% | +17.5% | 1.98% | 13.13倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
